Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Gains from Investment Securities (2020 - 2025)

BioAtla (BCAB) has 6 years of Gains from Investment Securities data on record, last reported at $2.1 million in Q3 2025.

  • For Q3 2025, Gains from Investment Securities rose 32.6% year-over-year to $2.1 million; the TTM value through Sep 2025 reached $536000.0, down 66.46%, while the annual FY2024 figure was $6.1 million, 2.83% down from the prior year.
  • Gains from Investment Securities reached $2.1 million in Q3 2025 per BCAB's latest filing, up from $297000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $6.2 million in Q1 2023 and bottomed at -$1.9 million in Q1 2025.
  • Average Gains from Investment Securities over 5 years is $1.3 million, with a median of $1.1 million recorded in 2021.
  • The widest YoY moves for Gains from Investment Securities: up 730.77% in 2025, down 31433.33% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at $1.1 million in 2021, then surged by 151.81% to $2.7 million in 2022, then skyrocketed by 127.06% to $6.2 million in 2023, then crashed by 74.29% to $1.6 million in 2024, then skyrocketed by 32.6% to $2.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $2.1 million in Q3 2025, $297000.0 in Q2 2025, and -$1.9 million in Q1 2025.